Vicapsys Life Sciences Stock Price Patterns
| VICP Stock | USD 1.50 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Vicapsys Life hype-based prediction, you can estimate the value of Vicapsys Life Sciences from the perspective of Vicapsys Life response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Vicapsys Life to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Vicapsys because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vicapsys Life after-hype prediction price | USD 1.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vicapsys |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vicapsys Life's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vicapsys Life After-Hype Price Density Analysis
As far as predicting the price of Vicapsys Life at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vicapsys Life or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Vicapsys Life, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vicapsys Life Estimiated After-Hype Price Volatility
In the context of predicting Vicapsys Life's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vicapsys Life's historical news coverage. Vicapsys Life's after-hype downside and upside margins for the prediction period are 1.50 and 1.50, respectively. We have considered Vicapsys Life's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vicapsys Life is very steady at this time. Analysis and calculation of next after-hype price of Vicapsys Life Sciences is based on 3 months time horizon.
Vicapsys Life Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Vicapsys Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vicapsys Life backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vicapsys Life, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.50 | 1.50 | 0.00 |
|
Vicapsys Life Hype Timeline
Vicapsys Life Sciences is at this time traded for 1.50. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Vicapsys is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Vicapsys Life is about 0.0%, with the expected price after the next announcement by competition of 1.50. About 46.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.02. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Vicapsys Life Sciences recorded a loss per share of 0.03. The entity last dividend was issued on the 2nd of November 2017. The firm had 1:100 split on the 2nd of November 2017. Given the investment horizon of 90 days the next forecasted press release will be any time. Check out Vicapsys Life Basic Forecasting Models to cross-verify your projections.Vicapsys Life Related Hype Analysis
Having access to credible news sources related to Vicapsys Life's direct competition is more important than ever and may enhance your ability to predict Vicapsys Life's future price movements. Getting to know how Vicapsys Life's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vicapsys Life may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CLTEF | Calliditas Therapeutics AB | 0.00 | 0 per month | 0.00 | 0.17 | 28.95 | (38.33) | 58,082 | |
| ZIVO | Zivo Bioscience | (0.36) | 7 per month | 9.74 | 0.01 | 19.84 | (20.79) | 55.70 | |
| RLFTY | Relief Therapeutics Holding | 0.00 | 0 per month | 19.52 | 0.09 | 43.93 | (31.43) | 231.63 | |
| HBPCF | Helix BioPharma Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ACHFF | Arch Biopartners | 0.00 | 0 per month | 0.00 | (0.06) | 4.17 | (6.82) | 34.54 | |
| INNMF | Amplia Therapeutics Limited | 0.00 | 0 per month | 10.21 | 0.09 | 29.87 | (20.83) | 80.91 | |
| PSYBF | PsyBio Therapeutics Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| RLFTF | Relief Therapeutics Holding | 0.00 | 0 per month | 0.00 | (0.04) | 10.91 | (18.67) | 78.78 | |
| OTLC | Oncotelic Therapeutics | 0.00 | 0 per month | 0.00 | (0.07) | 14.29 | (12.50) | 47.22 | |
| SNANF | Sona Nanotech | 0.00 | 0 per month | 0.00 | (0.10) | 9.09 | (11.43) | 26.29 |
Vicapsys Life Additional Predictive Modules
Most predictive techniques to examine Vicapsys price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vicapsys using various technical indicators. When you analyze Vicapsys charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vicapsys Life Predictive Indicators
The successful prediction of Vicapsys Life stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vicapsys Life Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vicapsys Life based on analysis of Vicapsys Life hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vicapsys Life's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vicapsys Life's related companies.
Pair Trading with Vicapsys Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vicapsys Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicapsys Life will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Vicapsys Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vicapsys Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vicapsys Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vicapsys Life Sciences to buy it.
The correlation of Vicapsys Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vicapsys Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vicapsys Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vicapsys Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Vicapsys Pink Sheet Analysis
When running Vicapsys Life's price analysis, check to measure Vicapsys Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicapsys Life is operating at the current time. Most of Vicapsys Life's value examination focuses on studying past and present price action to predict the probability of Vicapsys Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicapsys Life's price. Additionally, you may evaluate how the addition of Vicapsys Life to your portfolios can decrease your overall portfolio volatility.